Identification of human dihydroorotate dehydrogenase inhibitor by a pharmacophore-based virtual screening study

HIGHLIGHTS

  • who: Salvatore Galati and collaborators from the Department of Drug Science and Technology, University of Turin, Turin, Italy have published the research: Identification of Human Dihydroorotate Dehydrogenase Inhibitor by a Pharmacophore-Based Virtual Screening Study, in the Journal: Molecules 2022, 27, 3660. of 10/05/2022
  • what: The authors reported a screening study for the of new promising hDHODH inhibitors. These results validated the reliability of the in silico workflow and provided a valuable starting point for hit-to-lead and future lead optimization studies aimed at the development of new potent hDHODH inhibitors. of . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?